Trapnell BC, Whitsett JA. Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu Rev Physiol. 2002;64:775–802.

Article  CAS  PubMed  Google Scholar 

Hildebrandt J, Yalcin E, Bresser HG, et al. Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis. Orphanet J Rare Dis. 2014;9:171.

Article  PubMed  PubMed Central  Google Scholar 

Takaki M, Tanaka T, Komohara Y, et al. Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB. Respir Med Case Rep. 2016;19:89–93.

PubMed  PubMed Central  Google Scholar 

Beeckmans H, Ambrocio GPL, Bos S, et al. Allogeneic hematopoietic stem cell transplantation after prior lung transplantation for hereditary pulmonary alveolar proteinosis: a case report. Front Immunol. 2022;13:931153.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nishinakamura R, Wiler R, Dirksen U, et al. The pulmonary alveolar proteinosis in granulocyte macrophage colony-stimulating factor/interleukins 3/5 beta c receptor-deficient mice is reversed by bone marrow transplantation. J Exp Med. 1996;183(6):2657–62.

Article  CAS  PubMed  Google Scholar 

Hetzel M, Lopez-Rodriguez E, Mucci A, et al. Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis. Haematologica. 2020;105(4):1147–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martinez-Moczygemba M, Doan ML, Elidemir O, et al. Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRα gene in the X chromosome pseudoautosomal region 1. J Exp Med. 2008;205(12):2711–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Frémond ML, Hadchouel A, Schweitzer C, et al. Successful haematopoietic stem cell transplantation in a case of pulmonary alveolar proteinosis due to GM-CSF receptor deficiency. Thorax. 2018;73(6):590–2.

Article  PubMed  Google Scholar 

Ozcelik U, Aytac S, Kuskonmaz B, et al. Nonmyeloablative hematopoietic stem cell transplantation in a patient with hereditary pulmonary alveolar proteinosis. Pediatr Pulmonol. 2021;56(2):341–3.

Article  PubMed  Google Scholar 

Suzuki T, Sakagami T, Young LR, et al. Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy. Am J Respir Crit Care Med. 2010;182:1292–304.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandrowala A, Khan S, Kataria D, et al. The role of graft T-cell size in patients receiving alemtuzumab serotherapy for non-malignant disorders: results of an institutional protocol. Sci Rep. 2024;14(1):988.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pandrowala A, Sharma AN, Kakunje M, et al. Reduced toxicity conditioning and a high CD34+ cell dose can achieve full donor chimerism in DOCK8 deficiency. J Allergy Clin Immunol Glob. 2023;2(3):100106.

Article  PubMed  PubMed Central  Google Scholar 

Draijer C, Penke LRK, Peters-Golden M. Distinctive effects of GM-CSF and M-CSF on proliferation and polarization of two major pulmonary macrophage populations. J Immunol. 2019;202(9):2700–9.

Article  CAS  PubMed  Google Scholar 

Kitamura T, Uchida K, Tanaka N, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2000;162:658–62.

Article  CAS  PubMed  Google Scholar 

Dirksen U, Hattenhorst U, Schneider P, et al. Defective expression of granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 receptor common beta chain in children with acute myeloid leukemia associated with respiratory failure. Blood. 1998;92:1097–103.

CAS  PubMed  Google Scholar 

Campo I, Carey BC, Paracchini E, et al. Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients. Eur Respir J. 2024;63(1):2301233.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sykora KW, Beier R, Schulz A, et al. Treosulfan vs busulfan conditioning for allogeneic bmt in children with nonmalignant disease: a randomized phase 2 trial. Bone Marrow Transplant. 2024;59(1):107–16.

Article  CAS  PubMed  Google Scholar 

Williams KM, Cheng GS, Pusic I, et al. Fluticasone, azithromycin, and montelukast treatment for new-onset bronchiolitis obliterans syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(4):710–6.

Article  CAS  PubMed  Google Scholar 

Happle C, Lachmann N, Škuljec J, et al. Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis. Sci Transl Med. 2014;6(250):250ra113.

Article  PubMed  Google Scholar